Intact Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-700
| Closed | -$326K | – | 351 |
|
|
2024
Q3 | $326K | Buy |
+700
| New | +$326K | 0.01% | 243 |
|
|
2024
Q1 | – | Sell |
-1,900
| Closed | -$773K | – | 278 |
|
|
2023
Q4 | $773K | Sell |
1,900
-600
| -24% | -$244K | 0.03% | 207 |
|
|
2023
Q3 | $869K | Buy |
2,500
+500
| +25% | +$174K | 0.04% | 195 |
|
|
2023
Q2 | $704K | Sell |
2,000
-400
| -17% | -$141K | 0.03% | 204 |
|
|
2023
Q1 | $756K | Hold |
2,400
| – | – | 0.03% | 192 |
|
|
2022
Q4 | $693K | Buy |
+2,400
| New | +$693K | 0.03% | 194 |
|
|
2022
Q3 | – | Sell |
-2,600
| Closed | -$733K | – | 268 |
|
|
2022
Q2 | $733K | Sell |
2,600
-200
| -7% | -$56.4K | 0.02% | 201 |
|
|
2022
Q1 | $731K | Sell |
2,800
-1,600
| -36% | -$418K | 0.02% | 215 |
|
|
2021
Q4 | $966K | Sell |
4,400
-600
| -12% | -$132K | 0.02% | 207 |
|
|
2021
Q3 | $907K | Hold |
5,000
| – | – | 0.03% | 200 |
|
|
2021
Q2 | $1.01M | Hold |
5,000
| – | – | 0.03% | 192 |
|
|
2021
Q1 | $1.07M | Buy |
+5,000
| New | +$1.07M | 0.03% | 189 |
|
|
2018
Q4 | – | Sell |
-1,190
| Closed | -$229K | – | 262 |
|
|
2018
Q3 | $229K | Sell |
1,190
-220
| -16% | -$42.3K | 0.01% | 239 |
|
|
2018
Q2 | $240K | Buy |
1,410
+20
| +1% | +$3.4K | 0.01% | 224 |
|
|
2018
Q1 | $227K | Sell |
1,390
-210
| -13% | -$34.3K | 0.01% | 218 |
|
|
2017
Q4 | $240K | Buy |
1,600
+200
| +14% | +$30K | 0.01% | 214 |
|
|
2017
Q3 | $213K | Buy |
+1,400
| New | +$213K | 0.01% | 241 |
|
|
2017
Q2 | – | Sell |
-5,000
| Closed | -$547K | – | 281 |
|
|
2017
Q1 | $547K | Sell |
5,000
-2,300
| -32% | -$252K | 0.02% | 157 |
|
|
2016
Q4 | $538K | Buy |
7,300
+700
| +11% | +$51.6K | 0.02% | 187 |
|
|
2016
Q3 | $576K | Hold |
6,600
| – | – | 0.02% | 188 |
|
|
2016
Q2 | $567K | Hold |
6,600
| – | – | 0.02% | 193 |
|
|
2016
Q1 | $525K | Buy |
6,600
+4,900
| +288% | +$390K | 0.02% | 190 |
|
|
2015
Q4 | $214K | Buy |
+1,700
| New | +$214K | 0.01% | 244 |
|